These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28723237)

  • 1. Linking chanelopathies with endoplasmic reticulum associated degradation.
    O'Donnell BM; Mackie TD; Brodsky JL
    Channels (Austin); 2017 Nov; 11(6):499-501. PubMed ID: 28723237
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome.
    O'Donnell BM; Mackie TD; Subramanya AR; Brodsky JL
    J Biol Chem; 2017 Aug; 292(31):12813-12827. PubMed ID: 28630040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome mining yields putative disease-associated ROMK variants with distinct defects.
    Nguyen NH; Sarangi S; McChesney EM; Sheng S; Durrant JD; Porter AW; Kleyman TR; Pitluk ZW; Brodsky JL
    PLoS Genet; 2023 Nov; 19(11):e1011051. PubMed ID: 37956218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary computational and experimental evaluation of missense variants in the ROMK potassium channel.
    Ponzoni L; Nguyen NH; Bahar I; Brodsky JL
    PLoS Comput Biol; 2020 Apr; 16(4):e1007749. PubMed ID: 32251469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endosomal trafficking factors CORVET and ESCRT suppress plasma membrane residence of the renal outer medullary potassium channel (ROMK).
    Mackie TD; Kim BY; Subramanya AR; Bain DJ; O'Donnell AF; Welling PA; Brodsky JL
    J Biol Chem; 2018 Mar; 293(9):3201-3217. PubMed ID: 29311259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway.
    Seaayfan E; Defontaine N; Demaretz S; Zaarour N; Laghmani K
    J Biol Chem; 2016 Feb; 291(9):4487-502. PubMed ID: 26721884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous mutations of the gene for Kir 1.1 (ROMK) in antenatal Bartter syndrome presenting with transient hyperkalemia, evolving to a benign course.
    Cho JT; Guay-Woodford LM
    J Korean Med Sci; 2003 Feb; 18(1):65-8. PubMed ID: 12589089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes.
    Hum Mol Genet; 1997 Jan; 6(1):17-26. PubMed ID: 9002665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.
    Vollmer M; Koehrer M; Topaloglu R; Strahm B; Omran H; Hildebrandt F
    Pediatr Nephrol; 1998 Jan; 12(1):69-71. PubMed ID: 9502574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Druggability of the inward rectifier family: a hope for rare channelopathies?
    Denton JS
    Future Med Chem; 2014 Jun; 6(9):971-3. PubMed ID: 24547691
    [No Abstract]   [Full Text] [Related]  

  • 11. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins.
    Wagner CA; Loffing-Cueni D; Yan Q; Schulz N; Fakitsas P; Carrel M; Wang T; Verrey F; Geibel JP; Giebisch G; Hebert SC; Loffing J
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1373-80. PubMed ID: 18322017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
    Welling PA; Ho K
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F849-63. PubMed ID: 19458126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bartter's syndrome].
    Daniluk U; Kaczmarski M; Wasilewska J; Matuszewska E; Semeniuk J; Sidor K; Krasnow A
    Pol Merkur Lekarski; 2004 May; 16(95):484-9. PubMed ID: 15518434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with Bartter syndrome type I and II.
    Puricelli E; Bettinelli A; Borsa N; Sironi F; Mattiello C; Tammaro F; Tedeschi S; Bianchetti MG;
    Nephrol Dial Transplant; 2010 Sep; 25(9):2976-81. PubMed ID: 20219833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels.
    Sharma A; Linshaw MA
    Clin Exp Nephrol; 2011 Aug; 15(4):572-6. PubMed ID: 21431899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome mining yields new disease-associated ROMK variants with distinct defects.
    Nguyen NH; Sarangi S; McChesney EM; Sheng S; Porter AW; Kleyman TR; Pitluk ZW; Brodsky JL
    bioRxiv; 2023 May; ():. PubMed ID: 37214976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESCRT regulates surface expression of the Kir2.1 potassium channel.
    Kolb AR; Needham PG; Rothenberg C; Guerriero CJ; Welling PA; Brodsky JL
    Mol Biol Cell; 2014 Jan; 25(2):276-89. PubMed ID: 24227888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet.
    Bailey MA; Cantone A; Yan Q; MacGregor GG; Leng Q; Amorim JB; Wang T; Hebert SC; Giebisch G; Malnic G
    Kidney Int; 2006 Jul; 70(1):51-9. PubMed ID: 16710355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome.
    Jeck N; Derst C; Wischmeyer E; Ott H; Weber S; Rudin C; Seyberth HW; Daut J; Karschin A; Konrad M
    Kidney Int; 2001 May; 59(5):1803-11. PubMed ID: 11318951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.